Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 122724
Published online Oct 15, 2026. doi: 10.4251/wjgo.122724
Published online Oct 15, 2026. doi: 10.4251/wjgo.122724
Figure 3 The prognostic model for predicting survival.
A: The prognostic model for predicting 6-month and 9-month progression-free survival; B: The prognostic model for predicting 12-month, 15-month, and 18-month overall survival. PD-L1: Programmed death-ligand 1; PIIN score: Prognostic immune-inflammatory-nutritional score; MMR: Mismatch repair; PFS: Progression-free survival; ECOG: Eastern Cooperative Oncology Group; OS: Overall survival; CPS: Combined positive score; pMMR: Proficient mismatch repair; dMMR: Deficient mismatch repair.
- Citation: Hao QL, Li ZY, Yao ZY, Shen YM, Sun DS, Gao C, Jiang RR. Prognostic value of the prognostic immune-inflammatory-nutritional score in patients with advanced gastric cancer treated with immunochemotherapy. World J Gastrointest Oncol 2026; 18(10): 122724
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/122724.htm
- DOI: https://dx.doi.org/10.4251/wjgo.122724